UNSPSC 51102807: Acetic acid/desonide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102807 Acetic acid/desonide is a Commodity code, but the recent state and local procurement activity does not reflect purchases of this specific pharmaceutical compound. Instead, the opportunities tagged under the code show state and local health agencies and counties procuring pharmaceutical products through piggyback warehouse agreements and direct competitive bidding for public health supplies — in this case, antibiotics, opioid antagonists, and drug disposal systems rather than acetic acid or desonide formulations. The issuing bodies include state departments of public health and county governments pursuing centralized pharmaceutical supply contracts to support emergency preparedness, community health initiatives, and regulatory compliance. Procurement vehicles include piggyback arrangements through multi-state cooperative purchasing consortia (such as MMCAP Infuse) and traditional IFB processes conducted by individual counties.

The geographic activity in the recent record spans Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, for the supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium under IFB 26-482DPH-PREPD-B-53392, with no enterprise set-asides or domestic product preferences applied. Seminole County, Florida issued an IFB (60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2026, and potential FEMA funding. The code's recent activity reflects a mismatch between its nominal scope (acetic acid and desonide) and the actual pharmaceutical procurement categories state and local buyers are tagging it with.